We are pleased to present a new series of short PODCASTS and VIDEOS (12-15 minutes, followed by a panel discussion) which will address the latest in managing a population's cardiovascular risk. As a healthcare professional, you are on the move and require educational opportunities that are provided in short, engaging formats. Scroll down for more information.
Emelia J. Benjamin, MD, ScM
Cardiologist, Boston Medical Center; Professor, Medicine & Epidemiology, Boston University; Clinician Scientist, Framingham Heart Study; Assistant Provost, Faculty Development, Boston University Medical Campus
Deepak L. Bhatt, MD, MPH
Executive Director, Interventional Cardiovascular Programs, Brigham & Women's Hospital Heart & Vascular Center; Professor of Medicine, Harvard Medical School
Gray Ellrodt, MD
Chair of Medicine & Chief Quality Officer, Berkshire Health System; Professor of Medicine, University of Massachusetts School of Medicine
Series Host and Panelists@containerItem.RenderHeadingSizeTag("h2")>
Christopher B. Granger, MD
Professor of Medicine, Division of Cardiology, Department of Medicine, Duke University Medical Center; Director, Cardiac Intensive Care Unit, Duke University Medical Center
Norma M. Keller, MD
Director, NYC Health & Hospitals Cardiology Quality & Safety; Chief of Cardiology & Director of Critical Care Clerkship, Bellevue Hospital Center; Assistant Professor, Department of Medicine, New York University School of Medicine
Eldrin Foster Lewis, MD, MPH
Chief, Cardiovascular Medicine, Stanford Health; Professor of Medicine, Stanford University
Amarin Pharma is a proud sponsor of American Heart Association’s Controlling Cardiovascular Risk – The Next Frontier program. Program content was developed without input from Amarin.